These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 14675606)

  • 1. Neuron-specific enolase in patients with neurocysticercosis.
    Lima JE; Takayanagui OM; Garcia LV; Leite JP
    J Neurol Sci; 2004 Jan; 217(1):31-5. PubMed ID: 14675606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of neuron-specific enolase for assessing the severity and outcome in patients with neurological disorders.
    Lima JE; Takayanagui OM; Garcia LV; Leite JP
    Braz J Med Biol Res; 2004 Jan; 37(1):19-26. PubMed ID: 14689039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and cerebrospinal fluid S100B concentrations in patients with neurocysticercosis.
    Lima JE; Walz R; Tort A; Souza D; Portela L; Bianchin MM; Takayanagui OM; Leite JP
    Braz J Med Biol Res; 2006 Jan; 39(1):129-35. PubMed ID: 16400473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status epilepticus increases CSF levels of neuron-specific enolase and alters the blood-brain barrier.
    Correale J; Rabinowicz AL; Heck CN; Smith TD; Loskota WJ; DeGiorgio CM
    Neurology; 1998 May; 50(5):1388-91. PubMed ID: 9595992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Two cases of Creutzfeldt-Jakob disease with high neuron-specific enolase level in cerebrospinal fluid].
    Jimi T; Wakayama Y; Shibuya S; Hara H; Sagawa F; Hashizume Y
    Rinsho Shinkeigaku; 1989 Jan; 29(1):118-21. PubMed ID: 2663293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal CSF neuron-specific enolase and S-100 protein levels in patients with recent non-complicated tonic-clonic seizures.
    Palmio J; Peltola J; Vuorinen P; Laine S; Suhonen J; Keränen T
    J Neurol Sci; 2001 Jan; 183(1):27-31. PubMed ID: 11166790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated neuron-specific enolase and S100 calcium-binding protein B concentrations in cerebrospinal fluid of patients with anti-N-methyl-d-aspartate receptor encephalitis.
    Liu B; Xie Z; Liu G; Gu Y; Pan S; Wang H
    Clin Chim Acta; 2018 May; 480():79-83. PubMed ID: 29329729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Prognostic Performance between Neuron-Specific Enolase and S100 Calcium-Binding Protein B Obtained from the Cerebrospinal Fluid of Out-of-Hospital Cardiac Arrest Survivors Who Underwent Targeted Temperature Management.
    Kang C; Jeong W; Park JS; You Y; Min JH; Cho YC; Ahn HJ
    J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33917473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuron-specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children.
    Berger RP; Pierce MC; Wisniewski SR; Adelson PD; Clark RS; Ruppel RA; Kochanek PM
    Pediatrics; 2002 Feb; 109(2):E31. PubMed ID: 11826241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum neuron specific enolase - a novel indicator for neuropsychiatric systemic lupus erythematosus?
    Hawro T; Bogucki A; Krupińska-Kun M; Maurer M; Woźniacka A
    Lupus; 2015 Dec; 24(14):1492-7. PubMed ID: 26124236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of Fas protein in CSF of patients with neurocysticercosis.
    Camargo JA; Bertolucci PH
    Arq Neuropsiquiatr; 2012 Apr; 70(4):262-6. PubMed ID: 22510737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble Fas/FasLare elevated in the serum and cerebrospinal fluid of patients with neurocysticercosis.
    Chen X; Yu X; Wang Y; Zhu J; Gu J
    Parasitol Res; 2017 Nov; 116(11):3027-3036. PubMed ID: 28965226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of neuron-specific enolase levels in serum and cerebrospinal fluid of children with neurological diseases.
    Ko FJ; Chiang CH; Wu CC; Wu L
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1990 Mar; 6(3):137-43. PubMed ID: 2342156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuron-specific enolase levels as a marker for possible neuronal damage in idiopathic intracranial hypertension.
    Samancı Y; Samancı B; Şahin E; Altıokka-Uzun G; Küçükali Cİ; Tüzün E; Baykan B
    Acta Neurol Belg; 2017 Sep; 117(3):707-711. PubMed ID: 28220397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and CSF neuron-specific enolase in patients with West syndrome.
    Suzuki Y; Toribe Y; Goto M; Kato T; Futagi Y
    Neurology; 1999 Nov; 53(8):1761-4. PubMed ID: 10563625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder.
    Schmidt FM; Mergl R; Stach B; Jahn I; Schönknecht P
    World J Biol Psychiatry; 2015 Feb; 16(2):106-13. PubMed ID: 25264292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of neuron-specific enolase as a serum marker of metastatic melanoma.
    Sato S; Kato J; Sawada M; Horimoto K; Okura M; Hida T; Uhara H
    J Dermatol; 2020 Oct; 47(10):1141-1148. PubMed ID: 32734632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of HP10 antigen in serum for diagnosis and follow-up of subarachnoidal and intraventricular human neurocysticercosis.
    Fleury A; Hernández M; Avila M; Cárdenas G; Bobes RJ; Huerta M; Fragoso G; Uribe-Campero L; Harrison LJ; Parkhouse RM; Sciutto E
    J Neurol Neurosurg Psychiatry; 2007 Sep; 78(9):970-4. PubMed ID: 17337467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE) in Alzheimer's disease.
    Schmidt FM; Mergl R; Stach B; Jahn I; Gertz HJ; Schönknecht P
    Neurosci Lett; 2014 Jun; 570():81-5. PubMed ID: 24746933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Symptoms, Imaging Features and Cyst Distribution in the Cerebrospinal Fluid Compartments in Patients with Extraparenchymal Neurocysticercosis.
    Bazan R; Hamamoto Filho PT; Luvizutto GJ; Nunes HR; Odashima NS; Dos Santos AC; Elias Júnior J; Zanini MA; Fleury A; Takayanagui OM
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005115. PubMed ID: 27828966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.